Ralpancizumab (Anti-PCSK9)Ralpancizumab (Anti-PCSK9)
Move your mouse over image or click to enlarge

Ralpancizumab (Anti-PCSK9)

Ralpancizumab (Anti-PCSK9) is a monoclonal antibody targeting selective proprotein convertase subtilisin kexin 9 (PCSK9). It has the potential in hemorrhagic stroke, hypercholesterolemic, dyslipidemia treatment. MW 145.28 KD.
Cat# Size Price Qty Buy
A3022-1mg*25 1mg*25
£4,152.00
A3022-1mg*5 1mg*5
£1,384.00
A3022-1mg 1mg
£441.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A3022

Related Documents